• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于血液的生物标志物方法在子宫内膜癌和乳腺癌中的应用潜力:一项病例对照比较研究。

Potential of blood-based biomarker approaches in endometrium and breast cancer: a case-control comparison study.

机构信息

Department of Gynecology and Obstetrics, University Hospital Heidelberg, Im Neuenheimer Feld 440, 69120, Heidelberg, Germany.

Department of General Pediatrics, Division of Neuropediatrics and Metabolic Medicine, Center for Pediatric and Adolescent Medicine, University Hospital Heidelberg, Im Neuenheimer Feld 430, 69120, Heidelberg, Germany.

出版信息

Arch Gynecol Obstet. 2022 Nov;306(5):1623-1632. doi: 10.1007/s00404-022-06482-8. Epub 2022 Mar 13.

DOI:10.1007/s00404-022-06482-8
PMID:35284957
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9519681/
Abstract

PURPOSE

Endometrial carcinoma is the second most common gynecological malignancy. Until today lacking a screening tool. A blood-based biomarker could help address this need.

METHODS

The expression levels of 30 acylcarnitines, 18 amino acids, 6 miRNAs, and 7 DNA methylation sites were measured in blood samples from 331 women (20 EC, 14 benign uterine lesions (benign), 140 breast cancers (BC), 157 controls). Areas under the ROC curves (AUC), sensitivity (sens.) and specificity (spec.) were computed to identify the variables best distinguishing.

RESULTS

The best top ten markers for the four comparisons (cancer vs. cancer-free; EC vs. BC, EC vs. controls; EC vs. benign), were identified via AUC. Malonylcarnitine distinguished best patients with EC from controls (AUC: 0.827, sens. 80%, spec. 73.1%) or BC (AUC: 0.819, sens. 84.3%, spec. 80%) being most notable. Tryptophan best differentiated benign from EC (AUC: 0.846, sens. 70%, spec. 92.9%).

CONCLUSIONS

The levels of the analyzed blood markers yielded promising results in the detection of EC and warrant further evaluation.

摘要

目的

子宫内膜癌是第二常见的妇科恶性肿瘤。直到今天,还缺乏一种筛查工具。基于血液的生物标志物可以帮助满足这一需求。

方法

在 331 名女性(20 名子宫内膜癌患者、14 名良性子宫病变患者、140 名乳腺癌患者、157 名对照者)的血液样本中测量了 30 种酰基肉碱、18 种氨基酸、6 种 miRNA 和 7 种 DNA 甲基化位点的表达水平。计算了 ROC 曲线下的面积 (AUC)、灵敏度 (sens.) 和特异性 (spec.),以确定最佳区分变量。

结果

通过 AUC 确定了用于四种比较(癌症与无癌;子宫内膜癌与乳腺癌、子宫内膜癌与对照者、子宫内膜癌与良性)的最佳前 10 个标记物。丙二酰肉碱区分子宫内膜癌患者与对照者(AUC:0.827,灵敏度 80%,特异性 73.1%)或乳腺癌患者(AUC:0.819,灵敏度 84.3%,特异性 80%)的效果最佳。色氨酸最佳区分良性与子宫内膜癌(AUC:0.846,灵敏度 70%,特异性 92.9%)。

结论

分析的血液标志物水平在检测子宫内膜癌方面取得了有希望的结果,值得进一步评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6336/9519681/1ccb5a5fa518/404_2022_6482_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6336/9519681/f8c16e577e86/404_2022_6482_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6336/9519681/c142d8d45a41/404_2022_6482_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6336/9519681/1a40ca6886d7/404_2022_6482_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6336/9519681/1ccb5a5fa518/404_2022_6482_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6336/9519681/f8c16e577e86/404_2022_6482_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6336/9519681/c142d8d45a41/404_2022_6482_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6336/9519681/1a40ca6886d7/404_2022_6482_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6336/9519681/1ccb5a5fa518/404_2022_6482_Fig4_HTML.jpg

相似文献

1
Potential of blood-based biomarker approaches in endometrium and breast cancer: a case-control comparison study.基于血液的生物标志物方法在子宫内膜癌和乳腺癌中的应用潜力:一项病例对照比较研究。
Arch Gynecol Obstet. 2022 Nov;306(5):1623-1632. doi: 10.1007/s00404-022-06482-8. Epub 2022 Mar 13.
2
Discovery of potential serum and urine-based microRNA as minimally-invasive biomarkers for breast and gynecological cancer.发现潜在的血清和尿液中的 microRNA 作为用于乳腺癌和妇科癌症的微创生物标志物。
Cancer Biomark. 2020;27(2):225-242. doi: 10.3233/CBM-190575.
3
Mutually distinguishing microRNA signatures of breast, ovarian and endometrial cancers in vitro.在体外鉴别乳腺癌、卵巢癌和子宫内膜癌的 miRNA 特征。
Mol Med Rep. 2020 Nov;22(5):4048-4060. doi: 10.3892/mmr.2020.11466. Epub 2020 Aug 27.
4
Sperm-associated antigen 9 is a promising marker for early diagnosis of endometrial cancer.精子相关抗原9是子宫内膜癌早期诊断的一个有前景的标志物。
Asian Pac J Cancer Prev. 2013;14(12):7635-8. doi: 10.7314/apjcp.2013.14.12.7635.
5
Detection of endometrial cancer using tampon-based collection and methylated DNA markers.使用基于卫生棉条的采集和甲基化 DNA 标记物检测子宫内膜癌。
Gynecol Oncol. 2023 Jul;174:11-20. doi: 10.1016/j.ygyno.2023.04.014. Epub 2023 May 2.
6
Discovery and validation of methylation markers for endometrial cancer.子宫内膜癌甲基化标志物的发现与验证
Int J Cancer. 2014 Oct 15;135(8):1860-8. doi: 10.1002/ijc.28843. Epub 2014 Mar 31.
7
Endometrial Cancer Detection by DNA Methylation Analysis in Cervical Papanicolaou Brush Samples.基于宫颈巴氏刷样本中 DNA 甲基化分析的子宫内膜癌检测。
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241242637. doi: 10.1177/15330338241242637.
8
Identification of novel diagnostic biomarkers in endometrial cancer using targeted metabolomic profiling.采用靶向代谢组学分析鉴定子宫内膜癌的新型诊断生物标志物。
Adv Med Sci. 2021 Mar;66(1):46-51. doi: 10.1016/j.advms.2020.12.001. Epub 2020 Dec 24.
9
Analysis of DNA methylation in endometrial biopsies to predict risk of endometrial cancer.分析子宫内膜活检中的 DNA 甲基化,以预测子宫内膜癌的风险。
Gynecol Oncol. 2020 Mar;156(3):682-688. doi: 10.1016/j.ygyno.2019.12.023. Epub 2020 Jan 3.
10
Plasma-derived exosomal miR-15a-5p as a promising diagnostic biomarker for early detection of endometrial carcinoma.血浆衍生的外泌体 miR-15a-5p 作为一种有前途的诊断生物标志物,可用于早期检测子宫内膜癌。
Mol Cancer. 2021 Mar 29;20(1):57. doi: 10.1186/s12943-021-01352-4.

引用本文的文献

1
Multi-Steroid Profiling and Machine Learning Reveal Androgens as Candidate Biomarkers for Endometrial Cancer Diagnosis: A Case-Control Study.多类固醇分析与机器学习揭示雄激素作为子宫内膜癌诊断的候选生物标志物:一项病例对照研究。
Cancers (Basel). 2025 May 16;17(10):1679. doi: 10.3390/cancers17101679.
2
Unveiling DNA methylation: early diagnosis, risk assessment, and therapy for endometrial cancer.揭开DNA甲基化的面纱:子宫内膜癌的早期诊断、风险评估与治疗
Front Oncol. 2025 Jan 20;14:1455255. doi: 10.3389/fonc.2024.1455255. eCollection 2024.
3
Research Progress of DNA Methylation Markers for Endometrial Carcinoma Diagnosis.

本文引用的文献

1
Endometrial hyperplasia as a risk factor of endometrial cancer.子宫内膜增生作为子宫内膜癌的一个风险因素。
Arch Gynecol Obstet. 2022 Aug;306(2):407-421. doi: 10.1007/s00404-021-06380-5. Epub 2022 Jan 10.
2
Association of preoperative serum HE4 levels on the survival of patients with endometrial cancer.术前血清 HE4 水平与子宫内膜癌患者生存的关系。
Arch Gynecol Obstet. 2021 Nov;304(5):1335-1343. doi: 10.1007/s00404-021-06118-3. Epub 2021 Jun 9.
3
Global metabolomics profiling of colorectal cancer in Malaysian patients.马来西亚患者结直肠癌的全球代谢组学分析
子宫内膜癌诊断中DNA甲基化标志物的研究进展
J Cancer. 2025 Jan 1;16(3):812-820. doi: 10.7150/jca.104214. eCollection 2025.
4
Endometrial cancer diagnostic and prognostic algorithms based on proteomics, metabolomics, and clinical data: a systematic review.基于蛋白质组学、代谢组学和临床数据的子宫内膜癌诊断与预后算法:一项系统综述
Front Oncol. 2023 Apr 6;13:1120178. doi: 10.3389/fonc.2023.1120178. eCollection 2023.
5
Diagnostic Accuracy of Liquid Biomarkers for the Non-Invasive Diagnosis of Endometrial Cancer: A Systematic Review and Meta-Analysis.用于子宫内膜癌非侵入性诊断的液体生物标志物的诊断准确性:一项系统评价和荟萃分析
Cancers (Basel). 2022 Sep 25;14(19):4666. doi: 10.3390/cancers14194666.
Bioimpacts. 2021;11(1):33-43. doi: 10.34172/bi.2021.05. Epub 2020 Mar 24.
4
Endometrial cancer: A systematic review of HE4, REM and REM-B.子宫内膜癌:HE4、REMs 和 REM-B 的系统评价。
Clin Chim Acta. 2021 Apr;515:27-36. doi: 10.1016/j.cca.2020.12.029. Epub 2020 Dec 31.
5
The Association Between RAPSN Methylation in Peripheral Blood and Early Stage Lung Cancer Detected in Case-Control Cohort.外周血中RAPSN甲基化与病例对照队列中检测到的早期肺癌之间的关联
Cancer Manag Res. 2020 Nov 2;12:11063-11075. doi: 10.2147/CMAR.S275321. eCollection 2020.
6
Circular RNA circ_0000043 promotes endometrial carcinoma progression by regulating miR-1271-5p/CTNND1 axis.环状 RNA circ_0000043 通过调控 miR-1271-5p/CTNND1 轴促进子宫内膜癌进展。
Arch Gynecol Obstet. 2021 Apr;303(4):1075-1087. doi: 10.1007/s00404-020-05849-z. Epub 2020 Oct 31.
7
Metabolomics in endometrial cancer diagnosis: A systematic review.代谢组学在子宫内膜癌诊断中的应用:系统评价。
Acta Obstet Gynecol Scand. 2020 Sep;99(9):1135-1146. doi: 10.1111/aogs.13847. Epub 2020 Apr 9.
8
Amino acids in cancer.氨基酸与癌症
Exp Mol Med. 2020 Jan;52(1):15-30. doi: 10.1038/s12276-020-0375-3. Epub 2020 Jan 24.
9
Risk of postmenopausal hormone therapy and patient history factors for the survival rate in women with endometrial carcinoma.绝经后激素治疗与子宫内膜癌患者生存率的患者病史因素。
Arch Gynecol Obstet. 2020 Jan;301(1):289-294. doi: 10.1007/s00404-019-05414-3. Epub 2019 Dec 19.
10
Plasma metabolites as possible biomarkers for diagnosis of breast cancer.血浆代谢物可作为乳腺癌诊断的生物标志物。
PLoS One. 2019 Dec 3;14(12):e0225129. doi: 10.1371/journal.pone.0225129. eCollection 2019.